ARCHIVES

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

This article is from The Cancer Letter archive.

Vol. 24 No. 26 | July 3, 1998

Download PDF Visit The Full Archive

Related Articles

Alan Rabson Named Acting NCI Director

October 5, 2001

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Prostate Ultrasound Markers Concepts Approved by BSC

October 3, 1986

ONS Scientific Program Grows

June 20, 1980

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014